CTRI/2017/05/008559招募中未知
Clinical audit using Psoriasis Disability Index (PDI) and Psoriasis Area and Severity Index (PASI) for utility of homoeopathic medicine in psoriasis patients
ational Institute of Homoeopathy Ministry of AYUSH Govt of India0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients suffering from psoriasis over 3 months
- •2. Age 18-60 years
- •3. Both sexes
- •4. Patients willing to take part in the study and giving written consent
排除标准
- •1. Patients who are too sick for consultation
- •2. Unable to read patient information sheets and not giving consent to take part
- •3. Psoriasis with complications like erythroderma and pustules
- •4. Diagnosed cases of unstable psychiatric illness or other systemic disease affecting quality of life
- •5. Currently receiving homeopathic treatment for chronic condition(s)
- •6. Pregnant and lactating women
- •7. Self-reported immune-compromised state
- •8. Substance abuse and/or dependence
研究者
相似试验
已完成
不适用
PASIMAT: Automatic Measure of PASIPsoriasisNCT02808559Centre Hospitalier Universitaire de Nice30
已完成
不适用
The Disease Severity In Patients With PsoriasisPsoriasisNCT05943405Universitas Sebelas Maret33
已完成
不适用
A Clinical Observation on the Efficacy and Safety of Pulsed Dye Laser (PDL) in the Treatment of Nail PsoriasisNail PsoriasisNCT03946826xjpfW20
尚未招募
Unknown
Registry of Psoriasis Health Outcomes: A Longitudinal Real-world Collaboration (RePhlect) - A real-world, prospective, observational study of the comparative effectiveness of deucravacitinib in adults with plaque psoriasis in JapaPlaque psoriasisJPRN-UMIN000052957Bristol-Myers Squibb K.K.600
已完成
4 期
Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp PsoriasisScalp PsoriasisGenital PsoriasisNCT05969223AbbVie214